Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for AGEN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Total Long Term Debt (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 259.00M
March 31, 2026 303.41M
December 31, 2025 333.86M
September 30, 2025 339.83M
June 30, 2025 400.26M
March 31, 2025 414.41M
December 31, 2024 428.91M
September 30, 2024 418.17M
June 30, 2024 409.30M
March 31, 2024 344.91M
December 31, 2023 347.66M
September 30, 2023 352.03M
June 30, 2023 352.36M
March 31, 2023 355.16M
December 31, 2022 367.97M
September 30, 2022 348.54M
June 30, 2022 342.75M
March 31, 2022 312.64M
December 31, 2021 310.06M
September 30, 2021 305.14M
June 30, 2021 303.84M
March 31, 2021 296.28M
December 31, 2020 288.21M
September 30, 2020 271.26M
June 30, 2020 265.23M
Date Value
March 31, 2020 251.25M
December 31, 2019 243.56M
September 30, 2019 232.42M
June 30, 2019 232.96M
March 31, 2019 230.69M
December 31, 2018 13.83M
September 30, 2018 13.74M
June 30, 2018 13.74M
March 31, 2018 13.47M
December 31, 2017 126.83M
September 30, 2017 111.87M
June 30, 2017 111.77M
March 31, 2017 111.67M
December 31, 2016 112.16M
September 30, 2016 111.94M
June 30, 2016 123.27M
March 31, 2016 118.31M
December 31, 2015 114.47M
September 30, 2015 110.70M
June 30, 2015 11.43M
March 31, 2015 11.50M
December 31, 2014 6.027M
September 30, 2014 6.716M
June 30, 2014 7.429M
March 31, 2014 8.147M

Total Long Term Debt Definition

Represents a company's total debt maturing for more than 12 months of the reporting period.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Novavax, Inc. 297.32M
Amgen, Inc. 57.30B
Anika Therapeutics, Inc. 23.32M
BioCryst Pharmaceuticals, Inc. 834.73M
Imunon, Inc. 5.914M